Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-24-014996

Chief Scientific Officer sold 60,000 shares at an average $60.91 ($3,654,800)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Reich Kristian · Chief Scientific Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-14 Sale : show line 1 in the form 10b5-1 −10,000 $62.42 $624,200 3,017,483 I
2024-02-14 Sale : show line 2 in the form 10b5-1 −10,000 $62.43 $624,300 130,071 D
2024-02-15 Sale : show line 3 in the form 10b5-1 −10,000 $60.17 $601,700 3,007,483 I
2024-02-15 Sale : show line 4 in the form 10b5-1 −10,000 $60.16 $601,600 120,071 D
2024-02-16 Sale : show line 5 in the form 10b5-1 −10,000 $60.15 $601,500 2,997,483 I
2024-02-16 Sale : show line 6 in the form 10b5-1 −10,000 $60.15 $601,500 110,071 D
Open-market sales · 60,000 sh · avg $60.91 · $3,654,800
Loading xslF345X05/ownership.xml…